|
NUDT19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.825000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.184100E-02 |
| Normal-vs-Stage2 |
9.274600E-01 |
| Normal-vs-Stage3 |
2.187600E-01 |
| Normal-vs-Stage4 |
6.629400E-01 |
| Stage1-vs-Stage2 |
2.012800E-01 |
| Stage1-vs-Stage3 |
2.542100E-02 |
| Stage1-vs-Stage4 |
1.745400E-01 |
| Stage2-vs-Stage3 |
3.988200E-01 |
| Stage2-vs-Stage4 |
7.856200E-01 |
| Stage3-vs-Stage4 |
6.600800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.403580E-01 |
| Normal-vs-AfricanAmerican |
3.062600E-01 |
| Normal-vs-Asian |
3.318600E-01 |
| Caucasian-vs-AfricanAmerican |
8.908400E-01 |
| Caucasian-vs-Asian |
4.693700E-02 |
| AfricanAmerican-vs-Asian |
1.660780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.207220E-01 |
| Normal-vs-Female |
8.149400E-01 |
| Male-vs-Female |
1.600560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.389600E-01 |
| Normal-vs-Extreme_Weight |
6.864800E-03 |
| Normal-vs-Obese |
8.385600E-01 |
| Normal-vs-Extreme_Obese |
3.948000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.478000E-01 |
| Normal_Weight-vs-Obese |
5.092000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.914620E-01 |
| Extreme_Weight-vs-Obese |
3.539800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.250200E-02 |
| Obese-vs-Extreme_Obese |
3.816800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.564800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.781600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.201700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.698600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.547000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.420400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.877400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.326400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.666600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.755000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.001900E-02 |
| Normal-VS-Type2 PRCC |
4.474800E-01 |
| Normal-VS-KIRP CIMP |
7.913200E-01 |
| Normal-VS-Unclassified PRCC |
9.470000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.017800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.966400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.805980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.505600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.411200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.284400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.344000E-01 |
| Normal-vs-N1 |
2.478500E-02 |
| Normal-vs-N2 |
6.143100E-03 |
| N0-vs-N1 |
6.397400E-03 |
| N0-vs-N2 |
1.065380E-01 |
| N1-vs-N2 |
3.293900E-02 |
|
|
